Search Results - "Verbeek, Joost"

High-dose chemotherapy with stem cell rescue to treat stage III homologous deficient breast cancer: factors influencing clinical implementation by Verbeek, Joost G E, de Jong, Vincent M T, Wijnja, Hanna M, Jager, Agnes, Linn, Sabine C, Retèl, Valesca P, van Harten, Wim H

“…High-dose chemotherapy with autologous stem cell rescue (HDCT) is a promising treatment for patients with stage III, HER2-negative, homologous recombination…”
Get full text

Cost-utility, cost-effectiveness, and budget impact of Internet-based cognitive behavioral therapy for breast cancer survivors with treatment-induced menopausal symptoms by Verbeek, Joost G. E., Atema, Vera, Mewes, Janne C., van Leeuwen, Marieke, Oldenburg, Hester S. A., van Beurden, Marc, Hunter, Myra S., van Harten, Wim H., Aaronson, Neil K., Retèl, Valesca P.

“…Purpose Internet-based cognitive behavioral therapy (iCBT), with and without therapist support, is effective in reducing treatment-induced menopausal symptoms…”
Get full text

High-dose chemotherapy for patients with stage III breast cancer with homologous recombination deficiency: a discrete choice experiment among healthcare providers by Verbeek, Joost G E, Azarang, Leyla, Pilli, Luis E, De Jong, Vincent M T, Jager, Agnes, Linn, Sabine C, Retèl, Valesca P, Van Harten, Wim H

“…High-dose chemotherapy with autologous stem cell rescue (HDCT) is currently under investigation as a potential therapy for patients with stage III…”
Get full text

Early Cost-Effectiveness Analysis of Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy for Gastric Cancer Patients with Limited Peritoneal Carcinomatosis by Verbeek, Joost G. E., van der Sluis, Karen, Vollebergh, Marieke A., van Sandick, Johanna W., van Harten, Wim H., Retèl, Valesca P.

“…Background Gastric cancer patients with peritoneal carcinomatosis (PC) have a poor prognosis, with a median overall survival of 10 months when treated with…”
Get full text

Evaluation of [11 C]laniquidar as a tracer of P-glycoprotein: radiosynthesis and biodistribution in rats by Luurtsema, Gert, Schuit, Robert C, Klok, Rob P, Verbeek, Joost, Leysen, Josée E, Lammertsma, Adriaan A, Windhorst, Albert D

“…Abstract At present, P-glycoprotein (P-gp) function can be studied using positron emission tomography (PET) together with a labelled P-gp substrate such as ( R…”
Get full text

Quantification of Dynamic 11C-Phenytoin PET Studies by Mansor, Syahir, Boellaard, Ronald, Froklage, Femke E, Bakker, Esther D M, Yaqub, Maqsood, Voskuyl, Rob A, Schwarte, Lothar A, Verbeek, Joost, Windhorst, Albert D, Lammertsma, Adriaan

“…The overexpression of P-glycoprotein (Pgp) is thought to be an important mechanism of pharmacoresistance in epilepsy. Recently, (11)C-phenytoin has been…”
Get full text

Synthesis and preliminary preclinical evaluation of fluorine-18 labelled isatin-4-(4-methoxyphenyl)-3-thiosemicarbazone ([18F]4FIMPTC) as a novel PET tracer of P-glycoprotein expression by Verbeek, Joost, Eriksson, Jonas, Syvänen, Stina, Huisman, Marc, Schuit, Robert C., Molthoff, Carla F. M., Voskuyl, Rob A., de Lange, Elizabeth C., Lammertsma, Adriaan A., Windhorst, Albert D.

“…Background Several P-glycoprotein (P-gp) substrate tracers are available to assess P-gp function in vivo, but attempts to develop a tracer for measuring…”
Get full text

Synthesis and preclinical evaluation of [11 C]D617, a metabolite of (R)- [11 C]verapamil by Verbeek, Joost, Syvänen, Stina, Schuit, Robert C, Eriksson, Jonas, de Lange, Elizabeth C, Windhorst, Albert D, Luurtsema, Gert, Lammertsma, Adriaan A

“…Abstract Objectives (R) -[11 C]verapamil is widely used as a positron emission tomography (PET) tracer to evaluate P-glycoprotein (P-gp) functionality at the…”
Get full text

Carbon-11 labeled tracers for in vivo imaging P-glycoprotein function: kinetics, advantages and disadvantages by Luurtsema, G, Verbeek, G L, Lubberink, M, Lammertsma, A A, Dierckx, R, Elsinga, P, Windhorst, A D, van Waarde, A

“…P-glycoprotein (P-gp) is a drug efflux transporter with broad substrate specificity localized in the blood-brain barrier and in several peripheral organs. In…”
Get more information

Binding characterization of N‐(2‐chloro‐5‐thiomethylphenyl)‐N′‐(3‐[3H]3methoxy phenyl)‐N′‐methylguanidine ([3H]GMOM), a non‐competitive N‐methyl‐D‐aspartate (NMDA) receptor antagonist by Metaxas, Athanasios, van Berckel, Bart N. M., Klein, Pieter J., Verbeek, Joost, Nash, Emily C., Kooijman, Esther J. M., Renjaän, Véronique A., Golla, Sandeep S. V., Boellaard, Ronald, Christiaans, Johannes A. M., Windhorst, Albert D., Leysen, Josée E.

“…Labeled with carbon‐11, N‐(2‐chloro‐5‐thiomethylphenyl)‐N′‐(3‐methoxyphenyl)‐N′‐methylguanidine ([11C]GMOM) is currently the only positron emission tomography…”
Get full text

[11C]phenytoin revisited: synthesis by [11C]CO carbonylation and first evaluation as a P-gp tracer in rats by Verbeek, Joost, Eriksson, Jonas, Syvänen, Stina, Labots, Maaike, de Lange, Elizabeth C M, Voskuyl, Rob A, Mooijer, Martinus P J, Rongen, Marissa, Lammertsma, Adriaan A, Windhorst, Albert D

“…Background At present, several positron emission tomography (PET) tracers are in use for imaging P-glycoprotein (P-gp) function in man. At baseline, substrate…”
Get full text

Radiosynthesis and biodistribution of a histamine H3 receptor antagonist 4-[3-(4-piperidin-1-yl-but-1-ynyl)-[11C]benzyl]-morpholine: evaluation of a potential PET ligand by Airaksinen, Anu J, Jablonowski, Jill A, van der Mey, Margreet, Barbier, Ann J, Klok, Rob P, Verbeek, Joost, Schuit, Robert, Herscheid, Jacobus D M, Leysen, Josee E, Carruthers, Nicholas I, Lammertsma, Adriaan A, Windhorst, Albert D

“…The potent histamine H(3) receptor antagonist JNJ-10181457 (1) was successfully labeled with (11)C in a novel one-pot reaction sequence, with high chemical…”
Get full text

SHARING AND COLLECTING HOSPITAL-BASED HEALTH TECHNOLOGY ASSESSMENT REPORTS INTERNATIONALLY: IS AN EXTENSIVE PARTICIPATION OF STAKEHOLDERS REALISTIC? by Verbeek, Joost, Hiligsmann, Mickaël, Cicchetti, Americo, Marchetti, Marco

“…The emergence of new medical technologies and budget restrictions has led to a substantial increase in the use of hospital-based health technology assessment…”
Get more information

Recent Progress in Metal Catalyzed Direct Carboxylation of Aryl Halides and Pseudo Halides Employing CO 2 : Opportunities for 11 C Radiochemistry by Ahamed, Muneer, Verbeek, Joost, Funke, Uta, Lecina, Joan, Verbruggen, Alfons, Bormans, Guy

“…Carbon dioxide (CO 2 ) as a synthon in organic transformations is very useful, especially when combined with transition metal catalysts. CO 2 insertion on…”
Get full text

Recent Progress in Metal Catalyzed Direct Carboxylation of Aryl Halides and Pseudo Halides Employing CO2: Opportunities for 11C Radiochemistry by Ahamed, Muneer, Verbeek, Joost, Funke, Uta, Lecina, Joan, Verbruggen, Alfons, Bormans, Guy

“…Carbon dioxide (CO2) as a synthon in organic transformations is very useful, especially when combined with transition metal catalysts. CO2 insertion on…”
Get full text

Recent Progress in Metal Catalyzed Direct Carboxylation of Aryl Halides and Pseudo Halides Employing CO2: Opportunities for 11CRadiochemistry by Ahamed, Muneer, Verbeek, Joost, Funke, Uta, Lecina, Joan, Verbruggen, Alfons, Bormans, Guy

“…Carbon dioxide (CO2) as a synthon in organic transformations is very useful, especially when combined with transition metal catalysts. CO2 insertion on…”
Get full text

Parametric Methods for Dynamic ^sup 11^C-Phenytoin PET Studies by Mansor, Syahir, Yaqub, Maqsood, Boellaard, Ronald, Froklage, Femke E, de Vries, Anke, Bakker, Esther DM, Vokuyl, Rob A, Schwarte, Lothar A, Verbeek, Joost, Windhorst, Albert D, Lammertsma, Adriaan A

“…In this study, the performance of various methods for generating quantitative parametric images of dynamic 11C-phenytoin PET studies was evaluated. Methods:…”
Get full text

Parametric Methods for Dynamic (11)C-Phenytoin PET Studies by Mansor, Syahir, Yaqub, Maqsood, Boellaard, Ronald, Froklage, Femke E, de Vries, Anke, Bakker, Esther D M, Voskuyl, Rob A, Eriksson, Jonas, Schwarte, Lothar A, Verbeek, Joost, Windhorst, Albert D, Lammertsma, Adriaan A

“…In this study, the performance of various methods for generating quantitative parametric images of dynamic (11)C-phenytoin PET studies was evaluated. Methods:…”
Get full text

Quantification of Dynamic ^sup 11^C-Phenytoin PET Studies by Mansor, Syahir, Boellaard, Ronald, Froklage, Femke E, Bakker, Esther DM, Yaqub, Maqsood, Voskuyl, Rob A, Schwarte, Lothar A, Verbeek, Joost, Windhorst, Albert D, Lammertsma, Adriaan

“…The overexpression of P-glycoprotein (Pgp) is thought to be an important mechanism of pharmacoresistance in epilepsy. Recently, ...C-phenytoin has been…”
Get full text

Quantification of Dynamic sigma up 11 not equal to -Phenytoin PET Studies by Mansor, Syahir, Boellaard, Ronald, Froklage, Femke E, Bakker, Esther DM, Yaqub, Maqsood, Voskuyl, Rob A, Schwarte, Lothar A, Verbeek, Joost, Windhorst, Albert D, Lammertsma, Adriaan

“…The overexpression of P-glycoprotein (Pgp) is thought to be an important mechanism of pharmacoresistance in epilepsy. Recently, ...C-phenytoin has been…”
Get full text